PHASE II TRIAL OF NINTEDANIB IN PATIENTS WITH BEVACIZUMAB-RESISTANT RECURRENT EPITHELIAL OVARIAN, TUBAL, AND PERITONEAL CANCER

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Secord, AA; McCollum, M; Davidson, B; Broadwater, G; Squatrito, R; Havrilesky, L; Gabel, A; Nixon, A; Duska, L

Published Date

  • September 1, 2018

Published In

Volume / Issue

  • 28 /

Start / End Page

  • 457 - 457

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1525-1438

International Standard Serial Number (ISSN)

  • 1048-891X